iMed Studios launches Myobloc website for healthcare professionals

iMed Studios is proud to announce the launch of Myobloc.com, a website targeted to healthcare professionals searching for information on cervical dystonia, a movement disorder that causes the neck and shoulder muscles to contract and spasm involuntarily. Launched on June 30, 2008, along with the accompanying reimbursement services site, the sites serve to educate HCPs not only on cervical dystonia and Myobloc® (Botulinum Toxin Type B) Injectable Solution, but provide valuable information to help improve patient access, using a case management approach to assist healthcare professionals with the reimbursement process.

Developed as a collaborative effort with our sister agency, Brand Pharm, iMed spearheaded the information architecture, web design and development, as well as project management support for this project.

Myobloc® (Botulinum Toxin Type B) Injectable Solution is indicated for the treatment of patients with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical dystonia.